skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Results 1 2 next page
Refined by: resource type: Standards remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Cooperative Distributed GPU Power Capping for Deep Learning Clusters
Material Type:
Standards
Add to My Research

Cooperative Distributed GPU Power Capping for Deep Learning Clusters

Industrial Electronics, IEEE Transactions on, 2022, Vol.69, p.7244-7254

1982-2012 IEEE ;DOI: 10.1109/TIE.2021.3095790

Full text available

2
Mexiletine for treating the symptoms of myotonia in non-dystrophic myotonic disorders
Material Type:
Standards
Add to My Research

Mexiletine for treating the symptoms of myotonia in non-dystrophic myotonic disorders

NICE Guidance, 2021

Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

3
Tocilizumab for treating giant cell arteritis
Material Type:
Standards
Add to My Research

Tocilizumab for treating giant cell arteritis

NICE Guidance, 2018

Copyrights: © NICE 2018 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

4
Dostarlimab with platinum-based chemotherapy for treating advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiency
Material Type:
Standards
Add to My Research

Dostarlimab with platinum-based chemotherapy for treating advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiency

NICE Guidance, 2024

Copyrights: © NICE 2024 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

5
Avelumab with axitinib for untreated advanced renal cell carcinoma
Material Type:
Standards
Add to My Research

Avelumab with axitinib for untreated advanced renal cell carcinoma

NICE Guidance, 2020

Copyrights: © NICE 2020 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

6
Venetoclax with low dose cytarabine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitable
Material Type:
Standards
Add to My Research

Venetoclax with low dose cytarabine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitable

NICE Guidance, 2022

Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

7
SeHCAT (tauroselcholic [75 selenium] acid) for diagnosing bile acid diarrhoea
Material Type:
Standards
Add to My Research

SeHCAT (tauroselcholic [75 selenium] acid) for diagnosing bile acid diarrhoea

NICE Guidance, 2021

Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

8
Nivolumab for advanced squamous non-small-cell lung cancer after chemotherapy
Material Type:
Standards
Add to My Research

Nivolumab for advanced squamous non-small-cell lung cancer after chemotherapy

NICE Guidance, 2020

Copyrights: © NICE 2020 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

9
Midostaurin for untreated acute myeloid leukaemia
Material Type:
Standards
Add to My Research

Midostaurin for untreated acute myeloid leukaemia

NICE Guidance, 2018

Copyrights: © NICE 2018 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

10
Avatrombopag for treating primary chronic immune thrombocytopenia
Material Type:
Standards
Add to My Research

Avatrombopag for treating primary chronic immune thrombocytopenia

NICE Guidance, 2022

Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

11
Ceritinib for untreated ALK-positive non-small-cell lung cancer
Material Type:
Standards
Add to My Research

Ceritinib for untreated ALK-positive non-small-cell lung cancer

NICE Guidance, 2018

Copyrights: © NICE 2018 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

12
Metreleptin for treating lipodystrophy
Material Type:
Standards
Add to My Research

Metreleptin for treating lipodystrophy

NICE Guidance, 2021

Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

13
Solriamfetol for treating excessive daytime sleepiness caused by obstructive sleep apnoea
Material Type:
Standards
Add to My Research

Solriamfetol for treating excessive daytime sleepiness caused by obstructive sleep apnoea

NICE Guidance, 2022

Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

14
Venetoclax with azacitidine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitable
Material Type:
Standards
Add to My Research

Venetoclax with azacitidine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitable

NICE Guidance, 2022

Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

15
Lenalidomide with rituximab for previously treated follicular lymphoma
Material Type:
Standards
Add to My Research

Lenalidomide with rituximab for previously treated follicular lymphoma

NICE Guidance, 2020

Copyrights: © NICE 2020 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

16
Pembrolizumab plus chemotherapy for untreated, triple-negative, locally recurrent unresectable or metastatic breast cancer
Material Type:
Standards
Add to My Research

Pembrolizumab plus chemotherapy for untreated, triple-negative, locally recurrent unresectable or metastatic breast cancer

NICE Guidance, 2022

Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

17
PLGF-based testing to help diagnose suspected preterm pre-eclampsia
Material Type:
Standards
Add to My Research

PLGF-based testing to help diagnose suspected preterm pre-eclampsia

NICE Guidance, 2022

Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

18
Olaparib for adjuvant treatment of BRCA mutation-positive HER2-negative high-risk early breast cancer after chemotherapy
Material Type:
Standards
Add to My Research

Olaparib for adjuvant treatment of BRCA mutation-positive HER2-negative high-risk early breast cancer after chemotherapy

NICE Guidance, 2023

Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

19
Rimegepant for preventing migraine
Material Type:
Standards
Add to My Research

Rimegepant for preventing migraine

NICE Guidance, 2023

Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

20
Ivosidenib for treating advanced cholangiocarcinoma with an IDH1 R132 mutation after 1 or more systemic treatments
Material Type:
Standards
Add to My Research

Ivosidenib for treating advanced cholangiocarcinoma with an IDH1 R132 mutation after 1 or more systemic treatments

NICE Guidance, 2024

Copyrights: © NICE 2024 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

Results 1 2 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2018  (1)
  2. 2018 To 2018  (3)
  3. 2019 To 2019  (2)
  4. 2020 To 2021  (9)
  5. After 2021  (16)
  6. More options open sub menu

Searching Remote Databases, Please Wait